Type 1 Diabetes
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system and to test whether the AID System functions as it was designed to.
The results of this study are not yet available.
Your participation could last about 12 - 18 days and include up to 3 visits to the study center.
Here you can find out a bit more about the requirements for volunteers who took part in this study
- Participant must have type 1 diabetes for at least 2 years and must have used an insulin delivery system (insulin pump) for at least 1 year
- Participant must not have known allergies or history of hypersensitivity to insulin lispro
- Participant must not have had an episode of severe hypoglycemia (low blood sugar requiring help to treat) within the past 6 months
- Participant must not have had more than 1 episode of diabetic ketoacidosis (DKA) (a serious diabetes complication where the body produces excess blood acids called ketones) in the past 6 months